ORCID as entered in ROS

Select Publications
2009, 'Gene expression profiling of human pancreatic stellate cells and their roles in pancreatic cancer progression', in JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, WILEY-BLACKWELL PUBLISHING, INC, pp. A333 - A334, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200303&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'Heat shock proteins are induced during pancreatic stellate cell activation in pancreatic cancer', in Journal of Gastroenterology and Hepatology, Wiley, pp. A334 - A334, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200304&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'Heat Shock Proteins Are Induced During Pancreatic Stellate Cell Activation in Pancreatic Cancer', in GASTROENTEROLOGY, W B SAUNDERS CO-ELSEVIER INC, IL, Chicago, pp. A277 - A277, presented at Digestive Disease Week/110th Annual Meeting of the American-Gastroenterological-Association, IL, Chicago, 30 May 2009 - 04 June 2009
,2009, 'ESPAC-3(v2): A multicenter, international, open-label, randomized controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, FL, Orlando, presented at 45th Annual Meeting of the American-Society-of-Clinical-Oncology, FL, Orlando, 29 May 2009 - 02 June 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000276606603097&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'ESPAC-3(v2): A multicenter, international, open-label, randomized, controlled phase III trial of adjuvant 5-fluorouracil/folinic acid (5-FU/FA) versus gemcitabine (GEM) in patients with resected pancreatic ductal adenocarcinoma', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, FL, Orlando, presented at 45th Annual Meeting of the American-Society-of-Clinical-Oncology, FL, Orlando, 29 May 2009 - 02 June 2009, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000276607000024&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2009, 'Pancreatic stellate cells (stromal cells) migrate with pancreatic cancer cells to distant metastatic sites', in Journal of Gastroenterology and Hepatology, Wiley, pp. A334 - A335, presented at AGW, - , http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000270551200306&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'SAFETY AND PHARMACOKINETICS (PK) OF MOTESANIB DIPHOSPHATE WITH OR WITHOUT PANITUMUMAB (PMAB) PLUS FOLFIRI OR FOLFOX FOR THE TREATMENT OF METASTATIC COLORECTAL CANCER (MCRC)', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, SWEDEN, Stockholm, pp. 155 - 156, presented at 33rd European-Society-for-Medical-Oncology Congress, SWEDEN, Stockholm, 12 September 2008 - 16 September 2008, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000259973300467&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2008, 'Early detection of oxaliplatin-induced neurotoxicity: Getting it before it hurts', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, http://dx.doi.org/10.1200/jco.2008.26.15_suppl.15015
,2008, 'A prospective cohort study of fatigue after adjuvant therapy for breast cancer', in Psycho - Oncology, John Wiley & Sons Ltd, Chichester, W Sussex, England, pp. S36 - S37, presented at Psycho-Oncology 2008
,2008, 'Pancreatic stellate cells stimulate angiogenesis in pancreatic cancer and accompany pancreatic cancer cells to distant metastatic sites', in Pancreas, Lippincott Williams & Wilkins, Philadelphia, PA, USA, pp. 502 - 503, presented at Pancreas
,2008, 'DELIVERY OF LESS THAN INTENDED CISPLATIN (COOP) DOSE INTENSITY IN PATIENTS WITH LOCALLY ADVANCED HEAD AND NECK SQUAMOUS CELL CARCINOMA (LA-HNSCC) RECEIVING CONCURRENT CHEMORADIATION (CRT) CORRELATES WITH POORER OUTCOME', in RADIOTHERAPY AND ONCOLOGY, ELSEVIER IRELAND LTD, pp. S13 - S13
,2007, 'A placebo-controlled trial of Sertraline's effects on symptoms, well-being and survival in advanced cancer: The ZEST Trial', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY
,2007, 'ABC; An AGITG trial of fixed dose rate (FDR) gemcitabine (gem) and cisplatin for patients (pts) with advanced biliary tract cancer (ABC)', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000455043703565&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2007, 'When the goal is not cure: A randomized trial of a patient decision aid in advanced colorectal cancer', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000455043701477&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2007, 'Strongly primitive elements', in Golomb SW; Gong G; Helleseth T; Song HY (eds.), SEQUENCES, SUBSEQUENCES, AND CONSEQUENCES, SPRINGER-VERLAG BERLIN, CA, Univ So Calif, Los Angeles, pp. 24 - 36, presented at International Workshop on Sequences, Subsequences, and Consequences, CA, Univ So Calif, Los Angeles, 31 May 2007 - 02 June 2007
,2006, 'Pilot study of a clinical psychology service via videoconferencing for rural cancer patients in Australia', in PSYCHO-ONCOLOGY, WILEY-BLACKWELL, pp. S457 - S457, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000242413901519&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2006, 'A randomized phase II trial of pemetrexed plus irinotecan (ALIRI) versus leucovorin-modulated 5-FU plus irinotecan (FOLFIRI) in first-line treatment of locally advanced or metastatic colorectal cancer', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, TURKEY, Istanbul, pp. 118 - 118, presented at 31st Congress of the European-Society-for-Medical-Oncology, TURKEY, Istanbul, 29 September 2006 - 03 October 2006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000248078900349&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2006, 'Concurrent infusional 5-fluorouracil and 'protocol specific' 3D conformal radiotherapy is effective and safe in combination with 'sandwich' gemcitabine in the management of locally advanced pancreatic cancer', in ANNALS OF ONCOLOGY, OXFORD UNIV PRESS, SPAIN, Barcelona, pp. 21 - 21, presented at Satellite Symposium on New Horizons for Gastric Cancer held in conjunction with the 8th World Congress on Gastrointestinal Cancer, SPAIN, Barcelona, 29 June 2006, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000239782000009&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2006, 'Randomised phase II study evaluating weekly docetaxel in combination with cisplatin and 5FU or capecitabine in metastatic oesophago-gastric cancer.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, GA, Atlanta, pp. 194S - 194S, presented at 42nd Annual Meeting of the American-Society-of-Clinical-Oncology, GA, Atlanta, 02 June 2006 - 06 June 2006
,2006, 'The time taken to complete quality of life questionnaires in an advanced cancer trial.', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, GA, Atlanta, pp. 491S - 491S, presented at 42nd Annual Meeting of the American-Society-of-Clinical-Oncology, GA, Atlanta, 02 June 2006 - 06 June 2006
,2006, 'Pancreatic stellate cells stimulate pancreatic cancer growth and metastasis: Findings of a novel orthotopic model of pancreatic cancer', in Pancreas, Lippincott Williams & Wilkins, Philadelphia, PA, USA, -
,2005, 'Epithelial-stromal interactions in pancreatic cancer: do pancreatic cancer cells actively recruit host stromal cells for their own benefit?', in The Peter McCallum Institute (ed.), 6th Peter MacCallum Cancer Symposium, Molecular and Cell Biology of Cancer, Melbourne, pp. 21 - 21, presented at 6th Peter MacCallum Cancer Symposium, Molecular and Cell Biology of Cancer, Melbourne, 14 November 2005 - 16 November 2005
,2005, 'DOES EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITOR (EGFRI) SKIN TOXICITY AFFECT QOL? RESULTS FROM A NATIONAL CANCER INSTITUTE OF CANADA CLINICAL TRIALS GROUP (NCIC-CTG) RCT', in QUALITY OF LIFE RESEARCH, SPRINGER, pp. 2135 - 2135, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000520235700429&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2005, 'Combined modality therapy for pancreatic carcinoma: An australian pancreatic cancer group study of the addition of gemcitabine (G) to concurrent infusional 5-fluorouracil (CI5FI)and 3D conformal radiotherapy (RT)-final outcomesAbstract No: 4101', in Bhave AB (ed.), Journal of Clinical Oncology, Jitendar P Vij, Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India, pp. 203s - 203s, presented at 42nd Annual Meeting of the Amercian Society of Clinical Oncology, Atlanta, Georgia USA, 02 June 2005 - 06 June 2005
,2005, 'Specific haplotypic variations of the multidrug resistance 1 (ABCB1/MDR1) gene are associated with susceptibility or resistance to ulcerative colitis', in GASTROENTEROLOGY, W B SAUNDERS CO, IL, Chicago, pp. A441 - A442, presented at Annual Meeting of the American-Gastroenterological-Association/Digestive-Disease-Week, IL, Chicago, 14 May 2005 - 19 May 2005
,2005, 'Addition of gabapentin (G) to a modified FOLFOX regimen does not reduce neurotoxicity in patients (pts) with advanced colorectal cancer (CRC).', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, FL, Orlando, pp. 266S - 266S, presented at 41st Annual Meeting of the American-Society-of-Clinical-Oncology, FL, Orlando, 13 May 2005 - 17 May 2005, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000230326601475&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,2005, 'Selective internal radiation therapy (SIRT) plus systemic chemotherapy with irinotecan. A phase I dose escalation study', in JOURNAL OF CLINICAL ONCOLOGY, AMER SOC CLINICAL ONCOLOGY, FL, Orlando, pp. 296S - 296S, presented at 41st Annual Meeting of the American-Society-of-Clinical-Oncology, FL, Orlando, 13 May 2005 - 17 May 2005
,2004, '', in Journal of Clinical Oncology, Jitendar P Vij, Jaypee Brothers Medical Publishers (P) Ltd, New Delhi, India
,2000, 'Lacryglobin in human tears, a potential marker for cancer metastasis', in Australian and New Zealand Journal of Ophthalmology, Blackwell Science Asia, South Carlton, Australia, pp. 36 - 36, presented at Australasian Ophthalmic and Visual Sciences Meeting 2000, Sydney
,1997, 'A randomized study of paclitaxel versus cyclophosphamide/methotrexate/- fluorouracil/prednisone in previously untreated patients with advanced breast cancer: Preliminary results', in Seminars in Oncology, pp. S17 - S17
,1997, 'DOX-SL (stealth liposomal doxorubicin HCL) maintenance therapy after response in AIDS-related Kaposi's sarcoma', in JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, LIPPINCOTT-RAVEN PUBL, pp. 15 - 15, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WU25100049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1997, 'Prognosis in Kaposi's sarcoma as an initial and later AIDS associated illness', in JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES AND HUMAN RETROVIROLOGY, LIPPINCOTT-RAVEN PUBL, pp. 16 - 16, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1997WU25100051&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1997, 'Dox-SL maintenance therapy after response in AIDS-related Kaposis Sarcoma.', in J. AIDS and Human Retrovirology, presented at J. AIDS and Human Retrovirology
,1997, 'Long term follow-up of CEOP in the treatment of HIV related NHL.', in J. AIDS and Human Retrovirology, presented at J. AIDS and Human Retrovirology
,1997, 'Prognosis of Kaposi`s sarcoma as an initial and later AIDS associated illness.', in J. AIDS and Human Retrovirology, presented at J. AIDS and Human Retrovirology
,1996, 'DOX-SL (stealth liposomal doxorubicin HCl) maintenance therapy after response in AIDS-related Kaposi's sarcoma.', in AIDS, LIPPINCOTT WILLIAMS & WILKINS, pp. P133 - P133, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1996VU96300195&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1
,1993, 'Current status of clinical trials in HIV disease in Australia', in Journal of Acquired Immune Deficiency Syndromes, pp. S68 - S71
,1989, 'EFFECT OF DOSE ON BIOLOGICAL RESPONSE MODIFICATION BY INTERFERON-BETA-SER', in JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, LIPPINCOTT-RAVEN PUBL, pp. 327 - 328
,1989, 'EFFECTS OF INTERFERON AND ESTROGEN ON THE CYTOSKELETON OF HUMAN-BREAST TUMOR-CELL LINES', in JOURNAL OF BIOLOGICAL RESPONSE MODIFIERS, LIPPINCOTT-RAVEN PUBL, pp. 322 - 322
,1988, 'EFFECT OF ROUTE ON BIOLOGICAL RESPONSE MODIFICATION BY INTERFERON BETA-SER', in PROCEEDINGS OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH, AMER ASSOC CANCER RESEARCH, pp. 184 - 184
,'APACT: Phase III, Multicenter, International, Open-Label, Randomized Trial of Adjuvant nab-Paclitaxel Plus Gemcitabine (nab-P/G) Versus Gemcitabine (G) for Surgically Resected Pancreatic Adenocarcinoma', in PANCREAS, LIPPINCOTT WILLIAMS & WILKINS, pp. 1464 - 1464
,